Cancer Communications
indexed by SCI
BMC


Original article
First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
Xiangyang Yu, Xuewen Zhang, Zichen Zhang, Yongbin Lin, Yingsheng Wen, Yongqiang Chen, Weidong Wang and Lanjun Zhang
Cancer Communications 2018 38: 51
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/28/2018   doi:10.1186/s40880-018-0321-0
Original article
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
Yanjun Huang, Sichun Zhou, Caimei He, Jun Deng, Ting Tao, Qiongli Su, Kwame Oteng Darko, Mei Peng and Xiaoping Yang
Cancer Communications 2018 38: 50
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/27/2018   doi:10.1186/s40880-018-0319-7
Original article
Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining
Minjie Zhang, Liu Wang, Ke An†, Jun Cai, Guochao Li, Caiyun Yang, Huixian Liu, Fengxia Du, Xiao Han, Zilong Zhang, Zitong Zhao, Duanqing Pei, Yuan Long, Xin Xie, Qi Zhou and Yingli Sun
Cancer Communications 2018 38: 49
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/26/2018   doi:10.1186/s40880-018-0313-0
Original article
Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis
Xiuying Gu, Rongshou Zheng, Changfa Xia, Hongmei Zeng, Siwei Zhang, Xiaonong Zou, Zhixun Yang, He Li and Wanqing Chen
Cancer Communications 2018 38: 44
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/3/2018   doi:10.1186/s40880-018-0308-x
Original article
Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
Xinran Qiao, Xiaofei Wang, Yue Shang, Yi Li and Shu-zhen Chen
Cancer Communications 2018 38: 43
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/3/2018   doi:10.1186/s40880-018-0309-9
Original article
Differential incidence trends of colon and rectal cancers in Hong Kong: an age-period-cohort analysis
Bo Zhang, Shao-Hua Xie, and Ignatius Tak-sun Yu
Cancer Communications 2018 38: 42
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-28   doi:10.1186/s40880-018-0311-2
Case report
Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
Giovanni Brandi, Michela Venturi, Stefania De Lorenzo, Francesca Garuti, Giorgio Frega, Andrea Palloni, Ingrid Garajovà, Francesca Abbati, Gioconda Saccoccio, Rita Golfieri, Maria Abbondanza Pantaleo and Maria Aurelia Barbera
Cancer Communications 2018 38: 41
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-26   doi:10.1186/s40880-018-0312-1
Review
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Juan Liu, Cen Zhang, Wenwei Hu and Zhaohui Feng
Cancer Communications 2018 38: 40
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-26   doi:10.1186/s40880-018-0314-z
Original article
Age exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapy
Fuh Yong Wong, Wei Ying Tham, Wen Long Nei, Cindy Lim and Hui Miao
Cancer Communications 2018 38: 39
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-26   doi:10.1186/s40880-018-0310-3
Original article
Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses
Junichi Hiratsuka, Nobuhiko Kamitani, Ryo Tanaka, Eisaku Yoden, Ryuji Tokiya, Minoru Suzuki, Rolf F. Barth and Koji Ono
Cancer Communications 2018 38: 38
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-19   doi:10.1186/s40880-018-0297-9
Review
Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor
Ling-Wei Wang, Yen-Wan Hsueh Liu, Fong-In Chou and Shiang-Huei Jiang
Cancer Communications 2018 38: 37
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-19   doi:10.1186/s40880-018-0295-y
Commentary
A realistic appraisal of boron neutron capture therapy as a cancer treatment modality
Rolf F. Barth, Zizhu Zhang and Tong Liu
Cancer Communications 2018 38: 36
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-19   doi:10.1186/s40880-018-0280-5
Review
Boron delivery agents for neutron capture therapy of cancer
Rolf F. Barth, Peng Mi and Weilian Yang
Cancer Communications 2018 38: 35
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-19   doi:10.1186/s40880-018-0299-7
News and Views
Challenges and research opportunities for lung cancer screening in China
Zixing Wang, Yuyan Wang, Yao Huang, Fang Xue, Wei Han, Yaoda Hu, Lei Wang, Wei Song and Jingmei Jiang
Cancer Communications 2018 38: 34
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-7   doi:10.1186/s40880-018-0305-0
Original article
NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
Yuwen Wang, Jingjing Cheng, Dan Xie, Xiaofeng Ding, Hailing Hou, Xi Chen, Puchun Er, Furong Zhang, Lujun Zhao, Zhiyong Yuan, Qingsong Pang, Ping Wang and Dong Qian
Cancer Communications 2018 38: 33
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-5   doi:10.1186/s40880-018-0307-y
Original article
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
Jung Hoon Kim, Sang-Cheol Lee, Sung Yong Oh, Seo-Young Song, Namsu Lee, Eun Mi Nam, Soonil Lee, In Gyu Hwang, Hyo Rak Lee, Kyu Taek Lee, Sang-Byung Bae, Han Jo Kim, Joung Soon Jang, Do Hyoung Lim, Hyun Woo Lee, Seok Yun Kang and Jung Hun Kang
Cancer Communications 2018 38: 32
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2018-6-4   doi:10.1186/s40880-018-0304-1

<<    Page 2 of 4  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by BioMed Central

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China